OBJECTIVE: To evaluate the prevalence of and risk factors for extranasal methicillin-resistant Staphylococcus aureus (MRSA) colonization and its relationship to nasal colonization among veterans hospitalized for acute care. DESIGN: Prospective observational study. SETTING: Veterans Affairs (VA) acute care hospital in Boston, Massachusetts. PATIENTS: Convenience sample of 150 patients hospitalized within the previous 36 hours and screened for nasal MRSA who were not known to have an active MRSA infection or MRSA isolates recovered from a wound during the past 12 months. METHODS: Potential risk factors for MRSA colonization were assessed, and oropharynx, axilla, hand, perirectal, wound, and catheter insertion site samples were obtained for culture. MRSA was identified in chromogenic agar and confirmed by use of routine culture techniques. Nasal MRSA colonization was detected by means of polymerase chain reaction (PCR). RESULTS: Nasal swab samples analyzed by use of PCR yielded results positive for MRSA in 16 (11%) of 150 patients. Extranasal cultures yielded positive results for 3 (2%) of 134 patients who tested negative for nasal MRSA colonization and for 9 (56%) of 16 patients who tested positive for nasal MRSA colonization (odds ratio [OR], 56.1 [95% confidence interval {CI}, 12.4-254.6]; p < .001). The oropharynx was the most commonly colonized extranasal site (10 patients [7%]). Independent risk factors for extranasal MRSA colonization included nasal MRSA colonization (OR, 66.9 [95% CI, 11.8-379.7]; P < .001) and end-stage hepatic disease (OR, 98.5 [95% CI, 3.1-3,112.4]; P = .01). CONCLUSIONS: Extranasal MRSA colonization is infrequent among veterans admitted for acute care to VA Boston Healthcare System. Extranasal MRSA colonization was strongly associated with nasal MRSA colonization, which suggests that the VA MRSA Prevention Initiative is not missing a large number of MRSA-colonized patients by focusing on nasal-only screening.
OBJECTIVE: To evaluate the prevalence of and risk factors for extranasal methicillin-resistant Staphylococcus aureus (MRSA) colonization and its relationship to nasal colonization among veterans hospitalized for acute care. DESIGN: Prospective observational study. SETTING: Veterans Affairs (VA) acute care hospital in Boston, Massachusetts. PATIENTS: Convenience sample of 150 patients hospitalized within the previous 36 hours and screened for nasal MRSA who were not known to have an active MRSA infection or MRSA isolates recovered from a wound during the past 12 months. METHODS: Potential risk factors for MRSA colonization were assessed, and oropharynx, axilla, hand, perirectal, wound, and catheter insertion site samples were obtained for culture. MRSA was identified in chromogenic agar and confirmed by use of routine culture techniques. Nasal MRSA colonization was detected by means of polymerase chain reaction (PCR). RESULTS: Nasal swab samples analyzed by use of PCR yielded results positive for MRSA in 16 (11%) of 150 patients. Extranasal cultures yielded positive results for 3 (2%) of 134 patients who tested negative for nasal MRSA colonization and for 9 (56%) of 16 patients who tested positive for nasal MRSA colonization (odds ratio [OR], 56.1 [95% confidence interval {CI}, 12.4-254.6]; p < .001). The oropharynx was the most commonly colonized extranasal site (10 patients [7%]). Independent risk factors for extranasal MRSA colonization included nasal MRSA colonization (OR, 66.9 [95% CI, 11.8-379.7]; P < .001) and end-stage hepatic disease (OR, 98.5 [95% CI, 3.1-3,112.4]; P = .01). CONCLUSIONS: Extranasal MRSA colonization is infrequent among veterans admitted for acute care to VA Boston Healthcare System. Extranasal MRSA colonization was strongly associated with nasal MRSA colonization, which suggests that the VA MRSA Prevention Initiative is not missing a large number of MRSA-colonized patients by focusing on nasal-only screening.
Authors: Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee Journal: Infect Control Hosp Epidemiol Date: 2010-11 Impact factor: 3.254
Authors: Elisa K McEachern; John H Hwang; Katherine M Sladewski; Shari Nicatia; Carola Dewitz; Denzil P Mathew; Victor Nizet; Laura E Crotty Alexander Journal: Infect Immun Date: 2015-03-30 Impact factor: 3.441
Authors: Daniel J Livorsi; David J Livorsi; Sana Arif; Patricia Garry; Madan G Kundu; Sarah W Satola; Thomas H Davis; Byron Batteiger; Amy B Kressel Journal: Infect Control Hosp Epidemiol Date: 2015-01 Impact factor: 3.254
Authors: James A McKinnell; Susan S Huang; Samantha J Eells; Eric Cui; Loren G Miller Journal: Infect Control Hosp Epidemiol Date: 2012-12-21 Impact factor: 3.254
Authors: Lance R Peterson; Oliver Liesenfeld; Christopher W Woods; Stephen D Allen; David Pombo; Parul A Patel; Maitry S Mehta; Bradly Nicholson; DeAnna Fuller; Andrew Onderdonk Journal: J Clin Microbiol Date: 2010-03-24 Impact factor: 5.948
Authors: P E B Verwer; J O Robinson; G W Coombs; T Wijesuriya; R J Murray; H A Verbrugh; T Riley; J L Nouwen; K J Christiansen Journal: Eur J Clin Microbiol Infect Dis Date: 2011-09-10 Impact factor: 3.267
Authors: Daniel J Morgan; Hannah R Day; Jon P Furuno; Atlisa Young; J Kristie Johnson; Douglas D Bradham; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2010-10-28 Impact factor: 3.254